Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
22 Januar 2024 - 2:00PM
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage
pharmaceutical company that aims to discover and develop
transformational medicines for patients, today announced that
members of its management team will participate in the following
investor conferences:
Event: Guggenheim’s 6th Annual
Biotechnology Conference Date: February 7,
2024Location: NY, NYFireside
Chat: 9:00 AM ET
Event: Leerink Partners Global
Biopharma Conference 2024Date: March 11,
2024Location: Miami, FLFireside
Chat: 10:00 AM ET
Access to the live webcasts of these events, as
well as archived recordings, will be available under the “Events
and Publications” tab on the investor relations section of the
Centessa Pharmaceuticals website at
https://investors.centessa.com/events-presentations.
About Centessa
Pharmaceuticals Centessa Pharmaceuticals plc is a
clinical-stage pharmaceutical company that aims to discover and
develop transformational medicines for patients. Our programs span
discovery-stage to late-stage development and cover a range of
high-value indications in rare diseases and immuno-oncology. We
operate with the conviction that each one of our programs has the
potential to change the current treatment paradigm and establish a
new standard of care. For more information, visit www.centessa.com,
which does not form part of this release.
Contact:Kristen K. Sheppard,
Esq.SVP of Investor Relationsinvestors@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
Von Sep 2023 bis Sep 2024